Activation of RNase L by 2',5'-oligoadenylates. Biophysical characterization. 1997

J L Cole, and S S Carroll, and E S Blue, and T Viscount, and L C Kuo
Department of Antiviral Research, Merck Research Laboratories, West Point, Pennsylvania 19486, USA.

Ribonuclease L (RNase L) is an endoribonuclease that is activated upon binding of adenosine oligomers linked 2' to 5' to cleave viral and cellular RNAs. We recently proposed a model for activation in which activator A binds to monomer, E, to form EA, which subsequently dimerizes to the active form, E2A2 (Cole, J. L., Carroll, S. S., and Kuo, L. C. (1996) J. Biol. Chem. 271, 3978-3981). Here, we have employed this model to define the equilibrium constants for activator binding (Ka) and dimerization of EA to E2A2 (Kd) by equilibrium analytical ultracentrifugation and fluorescence measurements. Multi-wavelength sedimentation data were globally fit to the model above, yielding values of Ka = 1.69 microM and Kd = 17. 8 nM for 2',5'-linked adenosine trimer. Fluorescent conjugates of 2',5'-linked adenosine trimer with 7-hydroxycoumarin have been prepared. The coumarin emission anisotropy shows a large increases upon binding to RNase L. Analysis of anisotropy titrations yields values of Ka and Kd close to those obtained by sedimentation. The sedimentation parameters for unmodified 2',5'-linked adenosine trimer also agree with those obtained by enzyme kinetic methods (Carroll, S. S., Cole, J. L., Viscount, T., Geib, J., Gehman, J., and Kuo, L. C. (1997) J. Biol. Chem. 272, 19193-19198). Thus, the data presented here clearly define the energetics of RNase L activation and support the minimal activation model.

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D009843 Oligoribonucleotides A group of ribonucleotides (up to 12) in which the phosphate residues of each ribonucleotide act as bridges in forming diester linkages between the ribose moieties.
D004722 Endoribonucleases A family of enzymes that catalyze the endonucleolytic cleavage of RNA. It includes EC 3.1.26.-, EC 3.1.27.-, EC 3.1.30.-, and EC 3.1.31.-. Endoribonuclease
D004789 Enzyme Activation Conversion of an inactive form of an enzyme to one possessing metabolic activity. It includes 1, activation by ions (activators); 2, activation by cofactors (coenzymes); and 3, conversion of an enzyme precursor (proenzyme or zymogen) to an active enzyme. Activation, Enzyme,Activations, Enzyme,Enzyme Activations
D005454 Fluorescence Polarization Measurement of the polarization of fluorescent light from solutions or microscopic specimens. It is used to provide information concerning molecular size, shape, and conformation, molecular anisotropy, electronic energy transfer, molecular interaction, including dye and coenzyme binding, and the antigen-antibody reaction. Anisotropy, Fluorescence,Fluorescence Anisotropy,Polarization, Fluorescence,Anisotropies, Fluorescence,Fluorescence Anisotropies,Fluorescence Polarizations,Polarizations, Fluorescence
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000227 Adenine Nucleotides Adenine Nucleotide,Adenosine Phosphate,Adenosine Phosphates,Nucleotide, Adenine,Nucleotides, Adenine,Phosphate, Adenosine,Phosphates, Adenosine

Related Publications

J L Cole, and S S Carroll, and E S Blue, and T Viscount, and L C Kuo
June 2006, Journal of medicinal chemistry,
J L Cole, and S S Carroll, and E S Blue, and T Viscount, and L C Kuo
January 2012, Bioorganic & medicinal chemistry letters,
J L Cole, and S S Carroll, and E S Blue, and T Viscount, and L C Kuo
December 2014, Journal of virology,
J L Cole, and S S Carroll, and E S Blue, and T Viscount, and L C Kuo
September 2023, The Journal of general virology,
J L Cole, and S S Carroll, and E S Blue, and T Viscount, and L C Kuo
October 2003, Cancer research,
J L Cole, and S S Carroll, and E S Blue, and T Viscount, and L C Kuo
September 2010, Antiviral research,
J L Cole, and S S Carroll, and E S Blue, and T Viscount, and L C Kuo
February 2022, Bioorganic & medicinal chemistry,
J L Cole, and S S Carroll, and E S Blue, and T Viscount, and L C Kuo
March 1998, Nucleic acids research,
J L Cole, and S S Carroll, and E S Blue, and T Viscount, and L C Kuo
January 2005, Methods in molecular medicine,
J L Cole, and S S Carroll, and E S Blue, and T Viscount, and L C Kuo
April 1991, Biochemical and biophysical research communications,
Copied contents to your clipboard!